(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(0.97%) $80.00
(5.73%) $2.64
(1.44%) $2 419.80
(6.36%) $31.78
(2.18%) $1 094.70
(-0.02%) $0.920
(-0.18%) $10.68
(-0.27%) $0.787
(0.19%) $91.05
2 days till quarter result
(bmo 2024-05-20)
Expected move: +/- 12.88%
@ $2.71
Issued: 14 Feb 2024 @ 10:56
Return: 33.21%
Previous signal: Feb 14 - 09:30
Previous signal:
Return: -6.62 %
Live Chart Being Loaded With Signals
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States...
Stats | |
---|---|
Today's Volume | 173 087 |
Average Volume | 963 319 |
Market Cap | 197.24M |
EPS | $0 ( 2024-03-14 ) |
Next earnings date | ( $-0.210 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.25 |
ATR14 | $0.0120 (0.33%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-15 | Furlong Tammy | Sell | 300 | Restricted Stock Unit |
2024-05-15 | Furlong Tammy | Buy | 300 | Common Stock |
2024-05-15 | Furlong Tammy | Sell | 100 | Common Stock |
2024-03-16 | Ferra Joseph J Jr | Buy | 12 562 | Common Stock |
2024-03-16 | Ferra Joseph J Jr | Sell | 4 773 | Common Stock |
INSIDER POWER |
---|
78.22 |
Last 96 transactions |
Buy: 15 873 353 | Sell: 30 999 346 |
Volume Correlation
Elevation Oncology, Inc. Correlation
10 Most Positive Correlations | |
---|---|
TIOA | 0.939 |
KROS | 0.936 |
MSDA | 0.931 |
CRNT | 0.93 |
ULH | 0.924 |
BRIVU | 0.923 |
MOTNU | 0.917 |
TSCO | 0.917 |
ASLN | 0.917 |
HUGE | 0.917 |
10 Most Negative Correlations | |
---|---|
SRNGW | -0.936 |
RIDE | -0.931 |
IMBI | -0.927 |
TCFC | -0.923 |
FLNC | -0.917 |
OSTK | -0.916 |
ENNV | -0.913 |
EBIX | -0.911 |
CFRX | -0.91 |
CARA | -0.909 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Elevation Oncology, Inc. Correlation - Currency/Commodity
Elevation Oncology, Inc. Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-39 000.00 (0.00 %) |
EPS: | $-1.340 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-39 000.00 (0.00 %) |
EPS: | $-1.340 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-27 000.00 (0.00 %) |
EPS: | $-4.09 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.386 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Elevation Oncology, Inc.
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators